Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics in Strategic Deal
Repare Therapeutics Inc. (NASDAQ:RPTX) is one of the best Canadian stocks with huge upside potential.
Repare Therapeutics Inc. (RPTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 10,333,600 | $14,363,704 | 0.51% | |
| 2. | OrbiMed Advisors Samuel Isaly | 3,322,488 | $4,618,258 | 0.12% | |
| 3. | Redmile Group Jeremy Green | 1,586,174 | $2,204,782 | -16% | 0.23% |
| 4. | Citadel Investment Group Ken Griffin | 937,488 | $1,303,108 | 0% | |
| 5. | BioImpact Capital Mpm Capital | 819,924 | $1,139,694 | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.38 | 16,143 | $86,909.07 | 548,938 | 2023-11-16 | Filing | |
| $5.38 | 125,909 | $677,856.28 | 4,308,573 | 2023-11-16 | Filing | |
| $5.38 | 153,693 | $827,437.00 | 5,309,432 | 2023-11-16 | Filing | |
| $5.00 | 47,712 | $238,555.23 | 532,795 | 2023-11-15 | Filing | |
| $5.00 | 390,507 | $1,952,495.95 | 4,182,664 | 2023-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.14 | 3,596 | $4,099.44 | 227,813 | 2025-03-12 | Filing | |
| $1.14 | 5,611 | $6,396.54 | 80,297 | 2025-03-12 | Filing | |
| $1.14 | 6,884 | $7,847.76 | 54,786 | 2025-03-12 | Filing | |
| $1.14 | 21,179 | $24,144.06 | 124,394 | 2025-03-12 | Filing | |
| $4.63 | 2,491 | $11,533.33 | 107,558 | 2024-04-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,443,659 | $4,786,686 | 1.54% | |
| 2. | 2,646,657 | $3,678,853 | 4.48% | |
| 3. | 1,121,318 | $1,558,632 | 3.6% | |
| 4. | 355,292 | $493,856 | 0.59% | |
| 5. | 286,010 | $397,554 | 0% |
News See All
12 Best Canadian Stocks With Huge Upside Potential
Earlier on May 29, Invesco’s Brian Levitt appeared on CNBC's 'The Exchange' to discuss how he thinks now is the time to diversify your portfolio into other parts of the world.
10 Best Canadian Penny Stocks to Buy Now
As we navigate the complexities of 2024, Canada's economic landscape presents a unique blend of challenges and opportunities.
11 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this piece, we will take a look at 11 cheap small cap stocks to buy before the next breakout.
10 Oversold Canadian Stocks To Buy
In this piece, we will take a look at ten oversold Canadian stocks to buy.
5 Best Guru Stocks To Buy Now
The Allstate Corporation (NYSE:ALL) is an Illinois-based company that provides property, casualty, and other insurance products in the United States and Canada.
Analysts Are Downgrading These 5 Pharmaceutical Stocks
In this article, we present the 5 pharmaceutical stocks that are being downgraded by analysts.
10 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
Were Hedge Funds Right About Repare Therapeutics Inc. (RPTX)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Fund and Insider Trading News: Paul Marshall, Larry Robbins, Alden Global Capital, Square Inc (SQ), Repare Therapeutics Inc (RPTX), and More
Tribune Publishing’s largest shareholder, Alden Global Capital, said on Thursday it had offered to take full control of the owner of the Chicago Tribune in a deal that values the company at $520.6 million...
Billionaire Hedge Funds
